Psycho-Babble Medication Thread 396440

Shown: posts 1 to 3 of 3. This is the beginning of the thread.

Cymbalta

Posted by jms600 on September 28, 2004, at 16:58:50

Hi,

Can anyone give me some idea of the efficacy of this new drug? Is it any good for anxiety as well as depression? Is it any good at all!?!

Also does anyone know when it will be released in Britain?

Thanks!

Re: Cymbalta

Posted by hawkeye on September 28, 2004, at 17:55:58

In reply to Cymbalta, posted by jms600 on September 28, 2004, at 16:58:50

"EU Scientific Committee recommends approval of Cymbalta® and Xeristar® for treatment of major depressive episodes
17 Sep 2004

Eli Lilly and Company and Boehringer Ingelheim today announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes. The CHMP has recommended that the European Commission authorize the drug to be marketed. If approved, this pharmaceutical treatment for depression will be marketed throughout the European Union by Lilly under the brand name Cymbalta® and by Boehringer Ingelheim under the brand names Cymbalta and, in Greece, Italy and Spain, as Xeristar®.

The European Commission is expected to grant marketing authorization within the next few months. Duloxetine for major depressive disorder was recently approved by the U.S. Food and Drug Administration and launched in the United States."

http://www.medicalnewstoday.com/medicalnews.php?newsid=13575#

Re: Cymbalta

Posted by Paul_d_234 on September 29, 2004, at 20:05:32

In reply to Re: Cymbalta, posted by hawkeye on September 28, 2004, at 17:55:58

I'm doing fine on it (See Zoloft to Cymbalta) on this board for my journal.

Others are benefiting and some are not - pretty typical of most ADs - individual benefits will vary.

"EU Scientific Committee recommends approval of Cymbalta® and Xeristar® for treatment of major depressive episodes
> 17 Sep 2004
>
> Eli Lilly and Company and Boehringer Ingelheim today announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes. The CHMP has recommended that the European Commission authorize the drug to be marketed. If approved, this pharmaceutical treatment for depression will be marketed throughout the European Union by Lilly under the brand name Cymbalta® and by Boehringer Ingelheim under the brand names Cymbalta and, in Greece, Italy and Spain, as Xeristar®.
>
> The European Commission is expected to grant marketing authorization within the next few months. Duloxetine for major depressive disorder was recently approved by the U.S. Food and Drug Administration and launched in the United States."
>
> http://www.medicalnewstoday.com/medicalnews.php?newsid=13575#
>

This is the end of the thread.

Show another thread

Psycho-Babble Medication | Extras | FAQ

Dr. Bob is Robert Hsiung, MD, bob@dr-bob.org

Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.